Examkin

Question

Difficulty: Very hardMedical History Evaluation

A 42-year-old woman is evaluated in the pulmonary clinic for a 6-month history of progressive shortness of breath with exertion, a dry, hacking cough, and mild generalized fatigue. She also reports diffuse joint pains, particularly in her knees and wrists. She has no fever, chills, or night sweats. Medical history is notable for recurrent urinary tract infections, for which she takes prophylactic nitrofurantoin. Her surgical history includes an appendectomy at age 20. Social history reveals she smoked a half-pack of cigarettes daily for 10 years but quit 5 years ago. She currently lives with a pet parrot. Ten years ago, she relocated from the Ohio River Valley to her current city to work as a precision machinist at an aerospace manufacturing facility. Vital signs are within normal limits. Physical examination shows a few tender, violaceous nodules on her anterior shins. Lungs are clear to auscultation bilaterally. A recent chest radiograph demonstrated bilateral hilar lymphadenopathy. A subsequent transbronchial lung biopsy revealed multiple well-formed, noncaseating granulomas with no evidence of acid-fast bacilli or fungal organisms. Based on this patient's comprehensive history and preliminary evaluation, which of the following is the most appropriate next step to establish the definitive etiology?

  1. Peripheral blood beryllium lymphocyte proliferation testAnswer
  2. B
    Measurement of serum angiotensin-converting enzyme level
  3. C
    Serum avian precipitin panel
  4. D
    Mediastinoscopy with surgical lymph node biopsy
  5. E
    Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan of the chest

Answer

The most appropriate next step is a peripheral blood beryllium lymphocyte proliferation test.
The correct answer is the peripheral blood beryllium lymphocyte proliferation test. This patient's presentation (dyspnea, cough, erythema nodosum, bilateral hilar lymphadenopathy, and well-formed noncaseating granulomas) strongly resembles sarcoidosis. However, her occupational history as a precision machinist in aerospace manufacturing places her at high risk for beryllium exposure. Chronic Beryllium Disease (CBD) is a granulomatous lung disease that is clinically and histologically indistinguishable from sarcoidosis. The critical differentiating step is recognizing the occupational exposure in the patient's history and ordering a beryllium lymphocyte proliferation test (BeLPT). A positive BeLPT confirms beryllium sensitization and establishes the diagnosis of CBD, which is vital because primary management involves removing the patient from further beryllium exposure.

Step-by-Step Solution

1
Analyze the clinical presentation and histological findings.
The patient presents with symptoms, imaging (bilateral hilar lymphadenopathy), skin findings (erythema nodosum), and histology (noncaseating granulomas) that are classically associated with sarcoidosis.
Establishing the baseline clinical syndrome narrows the differential diagnosis to granulomatous diseases.
2
Evaluate the medical, social, and occupational history for specific risk factors.
The history contains multiple distractors (nitrofurantoin, Ohio River Valley, pet parrot) and one critical occupational exposure: working as a precision machinist in aerospace manufacturing.
Aerospace, nuclear, and ceramics manufacturing are high-risk industries for beryllium exposure.
3
Synthesize the exposure history with the clinical syndrome.
Chronic Beryllium Disease (CBD) is clinically, radiographically, and histologically indistinguishable from sarcoidosis.
Without specific testing, CBD is frequently misdiagnosed as sarcoidosis.
4
Determine the optimal diagnostic test to differentiate the etiologies.
The beryllium lymphocyte proliferation test (BeLPT) on peripheral blood or bronchoalveolar lavage fluid is the definitive test for beryllium sensitization and CBD.
Identifying CBD is critical because, unlike sarcoidosis, management requires immediate and permanent removal of the patient from the source of beryllium exposure.

Key Concept

Chronic beryllium disease (CBD) is clinically and histologically indistinguishable from sarcoidosis (presenting with bilateral hilar adenopathy and noncaseating granulomas). Identifying a relevant occupational history (e.g., aerospace, ceramics, metal machining) is critical, and the diagnosis is confirmed via the beryllium lymphocyte proliferation test (BeLPT).
Estimated Time:1m 30s
Rate this question

Topics

Medical History Evaluation

More questions from this topic